-+ 0.00%
-+ 0.00%
-+ 0.00%

Eikon Therapeutics director Francisco Ma. Fatima files initial beneficial ownership statement

PUBT·06/15/2026 20:31:35
Listen to the news
Eikon Therapeutics director Francisco Ma. Fatima files initial beneficial ownership statement
  • Eikon Therapeutics director Francisco Ma. Fatima disclosed a stock option for 85,937 common shares at an $8.96 exercise price.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eikon Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-271167), on June 15, 2026, and is solely responsible for the information contained therein.